Drug therapy: antiviral agents (second of two parts).
D000212:Acyclovir; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D002648:Child; D006147:Guanine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D006509:Hepatitis B / Q000188:drug therapy; D006561:Herpes Simplex / Q000188:drug therapy; D006801:Humans; D007372:Interferons / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D016030:Kidney Transplantation; D007962:Leukocytes / Q000378:metabolism; D019384:Nucleic Acid Synthesis Inhibitors; D014176:Protein Biosynthesis / Q000187:drug effects; D012330:RNA, Double-Stranded / Q000378:metabolism; D012367:RNA, Viral / Q000378:metabolism; D018139:Simplexvirus / Q000201:enzymology; D013937:Thymidine Kinase / Q000378:metabolism; D014184:Transplantation, Homologous; D014777:Virus Diseases / Q000517:prevention & control; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D019384:Nucleic Acid Synthesis Inhibitors; D012330:RNA, Double-Stranded; D012367:RNA, Viral; D006147:Guanine; D007372:Interferons; D013937:Thymidine Kinase; D000212:Acyclovir